A preliminary report of a phase II study of weekly topotecan in platinum-sensitive recurrent ovarian and peritoneal carcinoma

被引：0
|
作者：
Rodriguez, M
Method, MW
Lewandowski, G
Vaccarello, L
Ansari, RH
机构：
[1] Gynecol Oncol & Pelv Surg Associates, Columbus, OH USA
[2] Michiana Hematol Oncol, South Bend, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5063
引用
收藏
页码：464S / 464S
页数：1
相关论文
共 50 条
  • [1] Phase II study of weekly topotecan in patients with relapsed platinum-sensitive ovarian or peritoneal cancer.
    Morris, RT
    Alvarez, RD
    Malone, J
    Bryant, C
    Andrews, SJ
    Kilgore, L
    Phibbs, GD
    Heilbrun, L
    Munkarah, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 468S - 468S
  • [2] A phase I/II trial of weekly topotecan and carboplatin in potentially platinum-sensitive relapsed ovarian and peritoneal carcinoma
    Rose, PG
    Smrekar, M
    Haba, P
    Visser, C
    Beeler, JF
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : 714 - 719
  • [3] Weekly topotecan in patients with platinum-sensitive and platinum-resistant recurrent ovarian and peritoneal cancers.
    Tummala, M. K.
    Alagarsamy, S.
    Chyou, P.
    McGuire, W. P., III
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma
    Selle, F.
    Sevin, E.
    Ray-Coquard, I.
    Mari, V.
    Berton-Rigaud, D.
    Favier, L.
    Fabbro, M.
    Lesoin, A.
    Lortholary, A.
    Pujade-Lauraine, E.
    ANNALS OF ONCOLOGY, 2014, 25 (11) : 2191 - 2196
  • [5] Topotecan weekly bolus chemotherapy for relapsed platinum-sensitive ovarian and peritoneal cancers
    Morris, Robert
    Alvarez, Ronald D.
    Andrews, Stephen
    Malone, John
    Bryant, Christopher
    Heilbrun, Lance K.
    Smith, Daryn
    Schmip, Veronica
    Munkarah, Adnan
    GYNECOLOGIC ONCOLOGY, 2008, 109 (03) : 346 - 352
  • [6] Phase II evaluation of three-day topotecan in recurrent platinum-sensitive ovarian carcinoma - A gynecologic oncology group study
    Miller, DS
    Blessing, JA
    Lentz, SS
    McMeekin, DS
    CANCER, 2003, 98 (08) : 1664 - 1669
  • [7] A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma
    Kose, MF
    Sufliarsky, J
    Beslija, S
    Saip, P
    Tulunay, G
    Krejcy, K
    Minarik, T
    Fitzthum, E
    Hayden, A
    Melemed, A
    GYNECOLOGIC ONCOLOGY, 2005, 96 (02) : 374 - 380
  • [8] A phase II trial of weekly paclitaxel and every 3 weeks of carboplatin in potentially platinum-sensitive ovarian and peritoneal carcinoma
    Rose, PG
    Smrekar, M
    Fusco, N
    GYNECOLOGIC ONCOLOGY, 2005, 96 (02) : 296 - 300
  • [9] A phase I trial of weekly topotecan and carboplatin in potentially platinum sensitive ovarian and peritoneal carcinoma.
    Smrekar, M
    Buller, RE
    Haba, P
    Visser, C
    Rose, PG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 485S - 485S
  • [10] A phase II, multicenter trial of weekly topotecan in patients with recurrent platinum-sensitive epithelial cancers of the ovary and peritoneum
    Brown, J. V., III
    Rettenmaier, M. A.
    Lopez, K. L.
    Graham, C.
    Micha, J. P.
    Goldstein, B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (02) : 249 - 254
12345